期刊
CLINICS IN LIVER DISEASE
卷 12, 期 4, 页码 939-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2008.07.011
关键词
Fibrosis; Cirrhosis; Stellate cell; Extracellular matrix; Myofibroblast; Liver biopsy; Complication; Portal hypertension
资金
- NIH [R01 DK 50574, R01 DK 60338]
Chronic injury results in a wound healing response that eventually leads to fibrosis. The response is generalized, with features common among multiple organ systems. In the liver, various different types of injury lead to fibrogenesis, implying a common pathogenesis. Although several specific therapies for patients who have different liver diseases have been successfully developed, including antiviral therapies for those who have hepatitis B and hepatitis C virus infection, specific and effective antifibrotic therapy remains elusive. Over the past 2 decades, great advances in the understanding of fibrosis have been made and multiple mechanisms underlying hepatic fibrogenesis uncovered. Elucidation of these mechanisms has been of fundamental importance in highlighting novel potential therapies. Preclinical studies have indicated several putative therapies that might abrogate fibrogenesis. This article emphasizes mechanisms underlying fibrogenesis and reviews available and future therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据